Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.
NPJ Vaccines
; 9(1): 85, 2024 May 18.
Article
em En
| MEDLINE
| ID: mdl-38762525
ABSTRACT
Antigenic characterization of newly emerging SARS-CoV-2 variants is important to assess their immune escape and judge the need for future vaccine updates. To bridge data obtained from animal sera with human sera, we analyzed neutralizing antibody titers in human and hamster single infection sera in a highly controlled setting using the same authentic virus neutralization assay performed in one laboratory. Using a Bayesian framework, we found that titer fold changes in hamster sera corresponded well to human sera and that hamster sera generally exhibited higher reactivity.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article